BG

Business Context and Reporting Period

Company: Bunge Global SA
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal year ended December 31, 2024
Business Overview: Bunge is a leading global agribusiness and food company with integrated operations from farmer to consumer. It operates through four reportable segments: Agribusiness, Refined and Specialty Oils, Milling, and Sugar and Bioenergy. The company is incorporated in Switzerland and trades on the NYSE under the symbol "BG".

Key Financial Metrics (Year Ended Dec 31, 2024)

Material Changes vs. Prior Period

• Revenue Decline: Net sales decreased 11% to $53.1 billion, driven by lower average sales prices across all regions due to a more balanced supply and demand environment, particularly in Agribusiness processing and merchandising.
• Profitability Compression: Net income attributable to shareholders fell 49% to $1.1 billion. Total EBIT dropped 46% to $1.8 billion, primarily due to lower gross profit in the Agribusiness segment.
• Segment Performance:
  • Agribusiness: EBIT declined 53% to $1.3 billion due to lower gross profit, foreign exchange losses ($171 million), and impairment charges.
  • Refined and Specialty Oils: EBIT decreased 12% to $759 million, impacted by lower margins and foreign exchange losses.
  • Milling: EBIT increased 68% to $111 million, driven by higher gross profit despite lower sales prices.
  • Sugar and Bioenergy: EBIT increased 31% to $215 million, largely due to a $195 million gain on the sale of the company's 50% interest in BP Bunge Bioenergia.
• Debt Increase: Total debt rose to $6.2 billion from $4.9 billion, primarily due to the issuance of $2.0 billion in Senior Notes to fund the pending Viterra acquisition.

Guidance, Outlook, and Risks

• Pending Viterra Acquisition: Bunge is pursuing a stock and cash acquisition of Viterra Limited. The transaction is expected to close in the coming months pending regulatory approvals. Upon completion, total debt is expected to increase to approximately $13 billion. The deal includes a $400 million termination fee payable by Bunge if the deal fails due to antitrust issues.
• Capital Allocation: The company repurchased 12.2 million shares for $1.1 billion in 2024. A remaining authorization of approximately $800 million exists under the current share repurchase program. Capital expenditures for 2025 are projected to be between $1.5 billion and $1.7 billion.
• Key Risks:
  • Geopolitical: Ongoing war in Ukraine impacts operations (assets <3% of total) and creates supply chain disruptions. The company recognized $58 million in insurance recoveries related to the war in 2024.
  • Commodity Prices: Volatility in agricultural commodity, energy, and freight prices affects margins.
  • Regulatory: Compliance with the EU Deforestation Regulation (EUDR), effective December 2025, and new climate disclosure rules (CSRD, California Climate Accountability Package).
  • Integration: Risks associated with integrating Viterra, including potential failure to realize synergies and retention of key personnel.

Investor Verification Checklist

• Viterra Closing Status: Verify the timeline for regulatory approvals and the final closing date of the Viterra acquisition.
• Debt Servicing Capacity: Assess the impact of the projected $13 billion debt load on interest coverage ratios post-acquisition.
• Agribusiness Margins: Monitor the recovery of gross margins in the Agribusiness segment, which was the primary driver of the earnings decline.
• Foreign Exchange Exposure: Review the impact of currency fluctuations, particularly the Brazilian Real and Argentine Peso, on future earnings.
• Regulatory Compliance Costs: Evaluate the financial impact of implementing the EUDR and other emerging ESG disclosure requirements.